The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 22, 2016

Filed:

Apr. 29, 2013
Applicant:

Yeda Research and Development Co. Ltd., Rehovot, IL;

Inventors:

Irina Lavelin, Rehovot, IL;

Varda Rotter, Rehovot, IL;

Moshe Oren, Rehovot, IL;

Ami Navon, Rehovot, IL;

Zvi Kam, Rehovot, IL;

Benjamin Geiger, Rehovot, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/555 (2006.01); A61K 31/47 (2006.01); A61K 31/522 (2006.01); A61K 31/60 (2006.01); A61K 33/34 (2006.01); C07K 14/47 (2006.01); C12N 9/64 (2006.01); G01N 33/50 (2006.01); A61K 31/52 (2006.01);
U.S. Cl.
CPC ...
A61K 31/555 (2013.01); A61K 31/47 (2013.01); A61K 31/52 (2013.01); A61K 31/522 (2013.01); A61K 31/60 (2013.01); A61K 33/34 (2013.01); C07K 14/4746 (2013.01); C12N 9/6421 (2013.01); C12Y 304/25001 (2013.01); G01N 33/5035 (2013.01); C07K 2319/40 (2013.01); C07K 2319/60 (2013.01);
Abstract

A method of treating a disease in which inhibiting of a proteasome is advantageous is provided. The method comprises administering to the subject a therapeutically effective amount of a compound which binds to a proteasome of a cell, the compound comprising a copper bound to a ligand, the ligand being configured such that upon binding to the proteasome, the copper interacts with cysteine 31 of a Beta2 subunit of the proteasome and further interacts with cysteine 118 of a Beta3 subunit of the proteasome, thereby treating the disease. Additional novel proteasome inhibitors are also provided as well as methods of identifying proteasome inhibitors.


Find Patent Forward Citations

Loading…